Compositions and methods for the treatment of chronic pain

Abstract

The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula TT, formula III, formula IV, formula V, formula VI, formula VII, formula VIII, formula IX, formula X, formula XI, formula XII, formula XIII, formula XIV and formula XV and the methods for the treatment of chronic pain may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of chronic pain.

What is claimed is: 
     
         1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . A compound of Formula III: 
       
         
           
           
               
               
           
         
         and a pharmaceutically acceptable hydrates, solvates, prodrugs, enantiomers, and stereoisomers thereof, wherein 
         RH independently represents 
         caprylic acid, 1-hydroxy-2-naphthoic acid, 2,2-dichloroacetic acid, 2-hydroxyethanesulfonic acid, 2-oxoglutaric acid, 4-acetamidobenzoic acid, 4-aminosalicylic acid, acetic acid, adipic acid, ascorbic acid, aspartic acid, benzenesulfonic acid, benzoic acid, camphoric acid, camphor-10-sulfonic acid, capric acid (decanoic acid), caproic acid (hexanoic acid), carbonic acid, cinnamic acid, citric acid, cyclamic acid, dodecylsulfuric acid, ethane-1,2-disulfonic acid, ethanesulfonic acid, formic acid, fumaric acid, galactaric acid, gentisic acid, glucoheptonic acid, gluconic acid, glucuronic acid, glutamic acid, glutaric acid, glycerophosphoric acid, glycolic acid, hippuric acid, hydrobromic acid, isobutyric acid, lactic acid, lactobionic acid, lauric acid, maleic acid, malic acid, malonic acid, mandelic acid, methanesulfonic acid, naphthalene-1,5-disulfonic acid, naphthalene-2-sulfonic acid, nicotinic acid, nitric acid, oleic acid, oxalic acid, palmitic acid, pamoic acid, phosphoric acid, proprionic acid, pyroglutamic acid, salicylic acid, sebacic acid, stearic acid, succinic acid, sulfuric acid, tartaric acid, thiocyanic acid, toluenesulfonic acid, undecylenic acid, omega 3 fatty acids, omega 6 fatty acids, n-acetyl cysteine (nac), furoate, methyl furoate, ethyl furoate, aminocaproic acid, caproic acid, caprilic acid, capric acid, lauric acid, alpha lipoic acid, R-lipoic acid, myristic acid, myristoleic acid, palmitic acid, palmitoleic acid, phospholipids, phosphatidylcholine, oleic acid, elaidic acid, linoleic acid, linolenic acid, menthol, retinoic acid, vitamin A, retinol, linolelaidic acid, arachidonic acid, phospholipids, phosphatidylcholine, menthol, retinoic acid, vitamin a, retinol, retinal, isotretinoin, curcumin, tretinoin, α-carotene β-carotene retinol, d2 ergosterol, ergocalciferol, 7-dehydrocholesterol, cholecalciferol, 25-hydroxycholecalciferol, calcitriol (1,25-dihydroxycholecalciferol), calcitroic acid, d4 dihydroergocalciferol, alfacalcidol, dihydrotachysterol, calcipotriol, tacalcitol, paricalcitol, tocopherol, naphthoquinone, phylloquinone, menaquinones, menadione, menadiol, thiamine, acefurtiamine, allithiamine, benfotiamine, fursultiamine, octotiamine, prosultiamine, sulbutiamine, riboflavin, niacin, nicotinamide, pantothenic acid, dexpanthenol, pantethine, pyridoxine, pyridoxal phosphate, pyridoxamine, pyritinol, biotin, folic acid, dihydrofolic acid, folinic acid, levomefolic acid, adenosylcobalamin, cyanocobalamin, hydroxocobalamin, methylcobalamin, choline, ascorbic acid, dehydroascorbic acid, 1-docosanol or 
       
       
         
           
           
               
               
           
         
         wherein within the proviso R 1 , R 2 , R 3  independently represents 
       
       
         
           
           
               
               
           
         
       
     
     
         4 . (canceled) 
     
     
         5 . A compound of Formula V: 
       
         
           
           
               
               
           
         
         and a pharmaceutically acceptable hydrate, solvate, prodrug, enantiomer, and stereoisomer thereof, herein; 
         RH independently represents 
         phospholipids, phosphatidylcholine, menthol, retinoic acid, vitamin A, retinol, retinal, isotretinoin, curcumin, tretinoin, α-carotene β-carotene retinol, d2 ergosterol, ergocalciferol, 7-dehydrocholesterol, cholecalciferol, 25-hydroxycholecalciferol, calcitriol (1,25-dihydroxycholecalciferol), calcitroic acid, d4 dihydroergocalciferol, alfacalcidol, dihydrotachysterol, calcipotriol, tacalcitol, paricalcitol, tocopherol, naphthoquinone, phylloquinone, menaquinones, menadione, menadiol, thiamine, acefurtiamine, allithiamine, benfotiamine, fursultiamine, octotiamine, prosultiamine, sulbutiamine, riboflavin, niacin, nicotinamide, pantothenic acid, dexpanthenol, pantethine, pyridoxine, pyridoxal phosphate, pyridoxamine, pyritinol, biotin, folic acid, dihydrofolic acid, folinic acid, levomefolic acid, adenosylcobalamin, cyanocobalamin, hydroxocobalamin, methylcobalamin, choline, ascorbic acid, dehydroascorbic acid, 1-docosanol or 
       
       
         
           
           
               
               
           
         
         wherein within the proviso R 1 , R 2 , R 3  independently represents 
       
       
         
           
           
               
               
           
         
       
     
     
         6 .- 16 . (canceled) 
     
     
         17 . A pharmaceutical composition comprising a compound of  claim 3  and a pharmaceutically acceptable carrier. 
     
     
         18 . (canceled) 
     
     
         19 . A pharmaceutical composition comprising a compound of  claim 5  and a pharmaceutically acceptable carrier. 
     
     
         20 .- 30 . (canceled) 
     
     
         31 . The pharmaceutical composition of  claim 17 , wherein said pharmaceutical composition is formulated to treat a patient with an effective amount of said pharmaceutical composition by oral administration, delayed release or sustained release, transmucosal administration, syrup, topical, parenteral administration, injection, subdermal administration, oral solution, rectal administration, buccal administration or transdermal administration. 
     
     
         32 . (canceled) 
     
     
         33 . The pharmaceutical composition of  claim 19 , wherein said pharmaceutical composition is formulated to treat a patient with an effective amount of said pharmaceutical composition by oral administration, delayed release or sustained release, transmucosal administration, syrup, topical, parenteral administration, injection, subdermal administration, oral solution, rectal administration, buccal administration or transdermal administration. 
     
     
         34 .- 44 . (canceled) 
     
     
         45 . The pharmaceutical compositions of  claim 31 , wherein said pharmaceutical composition is formulated for the treatment of chronic pain, surgery pain, wound pain, ulcer pain, neuropathic pain, central and peripheral nerve damage pain. 
     
     
         46 . (canceled) 
     
     
         47 . The pharmaceutical compositions of  claim 33 , wherein said pharmaceutical composition is formulated for the treatment of chronic pain, surgery pain, wound pain, ulcer pain, neuropathic pain, central and peripheral nerve damage pain. 
     
     
         48 .- 57 . (canceled) 
     
     
         58 . A compound of  claim 5 , comprising of formula V: 
       
         
           
           
               
               
           
         
       
     
     
         59 . (canceled) 
     
     
         60 . A pharmaceutical composition comprising a compound of  claim 58  and a pharmaceutically acceptable carrier. 
     
     
         61 . The pharmaceutical composition of  claim 60 , wherein said pharmaceutical composition is formulated to treat a patient with an effective amount of said pharmaceutical composition by oral administration, delayed release or sustained release, transmucosal administration, syrup, topical, parenteral administration, injection, subdermal administration, oral solution, rectal administration, buccal administration or transdermal administration. 
     
     
         62 . The pharmaceutical compositions of  claim 61 , wherein said pharmaceutical composition is formulated for the treatment of chronic pain, surgery pain, wound pain, ulcer pain, neuropathic pain, central and peripheral nerve damage pain.